Keeping operational in COVID: pandemic planning and resilience
The challenges of running a start-up through a pandemic: Hiring
The Role of Public-Private Partnerships in the Future of Fusion Energy
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology
New analysis confirms value of UKI2S investing public money to commercialise public science
Corporate communications in the COVID-19 crisis
How to build a start-up: Launching early stage science companies
UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences
Spin out secures £1.1M for ground-breaking ‘supercharged’ cell therapies to treat solid tumours
Rapid test for gonorrhoea and chlamydia to be developed by University of Birmingham spinout
Expert Interview with Gilad Gershon: Selecting the right talent for your start-up
UKI2S was delighted to be a partner in the £8.5 million pilot Innovate UK (IUK) Investment Accelerator which funded feasibility studies in health and life sciences or infrastructure systems.
The Accelerator programme provided an IUK grant and an investment from UKI2S simultaneously, of up to £150,000 per company.
Please see here for our announcement of the companies we have funded through this initiative.